NCT02157636
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified
Clinical trial condition
Hemostatic Disorders
Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.
3,075 public trials
581 recruiting studies
Hemostatic Disorders trial results
NCT05274763
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
Completed
Stage I Multiple Myeloma Treatment
NCT00733538
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Service de Medecine interne, Hôpital l'ARCHET, CHU de Nice Nice, France
NCT06359067
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Assistance Publique - Hôpitaux de Paris (AP-HP) Paris, IDF, France
NCT03848845
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- GSK Investigational Site Atlanta, Georgia, United States
- GSK Investigational Site Indianapolis, Indiana, United States
- GSK Investigational Site Charlotte, North Carolina, United States
- GSK Investigational Site Madison, Wisconsin, United States
Completed
Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide
NCT06069024
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +16 more
- Locations
-
- the First Affiliated Hospital of Shandong First Medical University Jinan, Shandong, China
NCT05306587
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Odense University Hospital Odense, Denmark
Completed
Bone Healing During Ninlaro Exposure
NCT04028115
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Odense University Hospital Odense, Denmark
NCT01588015
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +198 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Completed
Isatuximab Single Agent Study in Japanese Relapsed AND Refractory Multiple Myeloma Patients
NCT02812706
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Investigational Site Number :392001 Nagoya, Aichi-ken, Japan
- Investigational Site Number :392005 Shibukawa-shi, Gunma, Japan
- Investigational Site Number :392010 Hiroshima, Japan
- Investigational Site Number :392015 Kanazawa, Ishikawa-ken, Japan